Menopause

FILE - In this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developing breast cancer nearly two decades after they stop taking the pills, long-term results from a big federal study suggest. (AP Photo/Damian Dovarganes, File)
December 13, 2019 - 10:38 am
SAN ANTONIO (AP) — Women who use certain types of hormones after menopause still have an increased risk of developing breast cancer nearly two decades after they stop taking the pills, long-term results from a big federal study suggest. Although the risk is very small, doctors say a new generation...
Read More
June 03, 2019 - 5:12 pm
CHICAGO (AP) — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world's largest cancer conference. Among those who have benefited is Roszell Mack Jr., who at age 87 is still able to...
Read More
June 03, 2019 - 2:01 pm
CHICAGO (AP) — In a story June 2 about prostate cancer drugs, The Associated Press erroneously described a study involving the drug Erleada. The study tested the drug in men at high risk of having their cancer spread beyond the prostate, not those in whom it already had spread. A corrected version...
Read More
This undated photo provided by Roszell Mack, Jr. in May 2019 shows him at his office in Lexington, Ky. At the age of 87, he is able to work nearly fulltime at the horse farm nine years after being diagnosed with lung cancer that had spread to his bones and lymph nodes. "I go in every day, I'm the first one there," said Mack, who helped test Merck's Keytruda, a therapy that helps the immune system see and fight cancer. "I'm feeling well and I have a good quality of life." The biggest drawback of these drugs: They often cost $100,000 or more a year, although what patients pay out of pocket varies by insurance, income and other things. (Courtesy Roszell Mack, Jr. via AP)
June 02, 2019 - 12:15 pm
CHICAGO (AP) — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world's largest cancer conference. Among those who have benefited is Roszell Mack Jr., who at age 87 is still able to...
Read More
In this Thursday, May 24, 2018 photo, Adine Usher, 78, meets with breast cancer study leader Dr. Joseph Sparano at the Montefiore and Albert Einstein College of Medicine in the Bronx borough of New York. Usher was one of about 10,000 participants in the study which shows women at low or intermediate risk for breast cancer recurrence may safely skip chemotherapy without hurting their chances of survival. (AP Photo/Kathy Young)
June 03, 2018 - 4:20 pm
CHICAGO (AP) — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk. The study is the largest ever done...
Read More
In this Thursday, May 24, 2018 photo, Adine Usher, 78, meets with breast cancer study leader Dr. Joseph Sparano at the Montefiore and Albert Einstein College of Medicine in the Bronx borough of New York. Usher was one of about 10,000 participants in the study which shows women at low or intermediate risk for breast cancer recurrence may safely skip chemotherapy without hurting their chances of survival. (AP Photo/Kathy Young)
June 03, 2018 - 7:32 am
CHICAGO (AP) — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk. The study is the largest ever done...
Read More
March 19, 2018 - 11:29 am
CHICAGO (AP) — In a study of women with menopause-related sexual discomfort, gels worked as well as prescription hormone tablets at reducing symptoms. The researchers say the results suggest low-cost, over-the-counter moisturizers might be the best option. Most women in the study reported some...
Read More
March 19, 2018 - 11:28 am
CHICAGO (AP) — In a study of women with menopause-related sexual discomfort, gels worked as well as prescription hormone tablets at reducing symptoms. The researchers say the results suggest low-cost, over-the-counter moisturizers might be the best option. Most women reported some relief from their...
Read More